Diaceutics PLC
DIUXF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $32,158 | $23,699 | $19,504 | $13,943 |
| % Growth | 35.7% | 21.5% | 39.9% | – |
| Cost of Goods Sold | $3,888 | $3,993 | $5,467 | $3,377 |
| Gross Profit | $28,270 | $19,706 | $14,037 | $10,566 |
| % Margin | 87.9% | 83.2% | 72% | 75.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $30,742 | $22,784 | $16,280 | $11,877 |
| SG&A Expenses | $30,742 | $22,784 | $13,706 | $10,253 |
| Sales & Mktg Exp. | $0 | $0 | -$2,574 | -$1,624 |
| Other Operating Expenses | -$17 | -$60 | $0 | $0 |
| Operating Expenses | $30,725 | $22,724 | $13,706 | $10,253 |
| Operating Income | -$2,455 | -$3,018 | $331 | $313 |
| % Margin | -7.6% | -12.7% | 1.7% | 2.2% |
| Other Income/Exp. Net | $547 | $580 | -$97 | -$88 |
| Pre-Tax Income | -$1,908 | -$2,438 | $478 | $293 |
| Tax Expense | -$205 | -$692 | -$246 | -$268 |
| Net Income | -$1,703 | -$1,746 | $724 | $561 |
| % Margin | -5.3% | -7.4% | 3.7% | 4% |
| EPS | -0.02 | -0.021 | 0.009 | 0.007 |
| % Growth | 2.4% | -340.7% | 28.4% | – |
| EPS Diluted | -0.02 | -0.021 | 0.008 | 0.007 |
| Weighted Avg Shares Out | 84,311 | 84,227 | 84,150 | 83,936 |
| Weighted Avg Shares Out Dil | 84,454 | 84,227 | 86,090 | 84,942 |
| Supplemental Information | – | – | – | – |
| Interest Income | $601 | $646 | $111 | $0 |
| Interest Expense | $54 | $66 | $122 | $88 |
| Depreciation & Amortization | $4,627 | $4,773 | $3,008 | $1,799 |
| EBITDA | $2,773 | $2,401 | $3,608 | $2,112 |
| % Margin | 8.6% | 10.1% | 18.5% | 15.1% |